TyraTech, Inc. USA Pest Control Patents Secured (3765F)
April 24 2014 - 2:00AM
UK Regulatory
TIDMTYR TIDMTYRU
RNS Number : 3765F
TyraTech, Inc.
24 April 2014
24 April 2014
TyraTech, Inc.
("TyraTech" or the "Company")
USA patents for pest control compositions secured
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company
focusing on nature-derived insect and parasite control products, is
pleased to announce that the Company has received notice from the
United States Patent and Trademark Office ("USPTO") granting two
new patents for the Company's novel pest control compositions.
The first patent covers a range of current and pipeline animal
health products, including those that will be sold by Novartis
Animal Health US, Inc. for the control of flies, cockroaches and
other insects in production animal facilities and premises. This
patent also covers products sold into the professional pest control
and commercial/institutional markets by Envance Technologies, LLC,
which is TyraTech's joint venture with AMVAC Chemical Corporation.
The patent has a 20-year term, which expires in 2027.
The second patent covers TyraTech's Extend(TM) technology, which
harnesses the synergy between natural and synthetic compounds to
achieve increased efficacy while reducing the environmental
footprint of synthetic pesticides. This patent supports a number of
the Company's animal health pipeline products, as well as pipeline
products from Envance Technologies. The patent has a 20-year term,
which expires in 2029.
The issuance of these patents raises TyraTech's patent portfolio
to 21 granted United States and international patents protecting
its proprietary screening platform and compositions. The Company
currently has 50 United States and international patent
applications pending.
Bruno Jactel, Chief Executive Officer, said: "These new patents
are a testimony to the quality and innovation behind TyraTech's
technology and products. More importantly they will provide
protection for TyraTech's products that are already in the market
and for products that TyraTech is currently developing. Our
research and development teams are continually working to develop
new products and formulations that are patentable with the
objective of strengthening our growth platform."
For further information please contact:
TyraTech Inc.
Alan Reade, Non-Executive Chairman Tel: +44 78 4197 8709
Bruno Jactel, Chief Executive Officer Tel: +1 919 415 4340
SPARK Advisory Partners Limited, Nominated Adviser
Matt Davis / Mark Brady Tel: +44 20 3368 3551
Allenby Capital Limited, Joint Broker
Chris Crawford Tel: +44 20 3328 5656
Whitman Howard, Joint Broker
Ranald McGregor-Smith/ Niall Devins Tel: 44 20 7087 4550
Walbrook, Financial PR and IR
Bob Huxford /Guy McDougall (Public Relations) Tel: +44 20 7933 8792
Paul Cornelius (Investor Relations) Tel: +44 20 7933 8794
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBIGDSUBDBGSX
Tyratech (LSE:TYR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tyratech (LSE:TYR)
Historical Stock Chart
From Jul 2023 to Jul 2024